Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sideris

Showing results (1161-1170 of 1,209) with videos related to

Pageof 121
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Structure-based design of thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Michael Siu, Richard Goldsmith, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|December 22, 2021
Establishing a priori and a posteriori predictive models to assess patients' peak skin dose in interventional cardiology. Part 2: results of the VERIDIC projectJoelle Ann Feghali, Julie Delépierre, Olivera Ciraj Belac, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|December 27, 2021
Patient exposure dose in interventional cardiology per clinical and technical complexity levels. Part 1: results of the VERIDIC projectJoelle Ann Feghali, Julie Delépierre, Olivera Ciraj Belac, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort studyMonika Sobocan, Dhivya Chandrasekaran, Michail Sideris, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseSharada Labadie, Peter S Dragovich, Jinhua Chen, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 24, 2024
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerSamuel Oxley, Sarah Ahmed, Kathryn Baxter, et al.
European Urology Oncology|July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative AnalysisPasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerSamuel Oxley, Sarah Ahmed, Kathryn Baxter, et al.
European Heart Journal|August 29, 2015
Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantationIsrael M Barbash, Marco Barbanti, John Webb, et al.
Pageof 121

Showing results (1161-1170 of 1,209) with videos related to

Sort By:
Pageof 121
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Structure-based design of thienobenzoxepin inhibitors of PI3-kinaseSteven T Staben, Michael Siu, Richard Goldsmith, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|December 22, 2021
Establishing a priori and a posteriori predictive models to assess patients' peak skin dose in interventional cardiology. Part 2: results of the VERIDIC projectJoelle Ann Feghali, Julie Delépierre, Olivera Ciraj Belac, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|December 27, 2021
Patient exposure dose in interventional cardiology per clinical and technical complexity levels. Part 1: results of the VERIDIC projectJoelle Ann Feghali, Julie Delépierre, Olivera Ciraj Belac, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort studyMonika Sobocan, Dhivya Chandrasekaran, Michail Sideris, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenaseSharada Labadie, Peter S Dragovich, Jinhua Chen, et al.
Journal of Medicinal Chemistry|November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutationEmily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 24, 2024
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerSamuel Oxley, Sarah Ahmed, Kathryn Baxter, et al.
European Urology Oncology|July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative AnalysisPasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerSamuel Oxley, Sarah Ahmed, Kathryn Baxter, et al.
European Heart Journal|August 29, 2015
Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantationIsrael M Barbash, Marco Barbanti, John Webb, et al.
Pageof 121